Emanuel Tschannen
Directeur/Bestuurslid bij Dottikon Es America, Inc.
Oorsprong van het eerstegraads netwerk van Emanuel Tschannen
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
University of Bern
21
| College/University | Other Consumer Services | 21 |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Public Company | Chemicals: Specialty | 7 | |
Dottikon Es America, Inc.
1
| Subsidiary | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Emanuel Tschannen via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
THERMOGENESIS HOLDINGS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
UBS | Investment Managers | Comptroller/Controller/Auditor Corporate Officer/Principal | |
GEBERIT AG | Building Products | Sales & Marketing | |
BERNER KANTONALBANK AG | Regional Banks | Chief Operating Officer Director/Board Member | |
BACHEM HOLDING AG | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
SCHWEIZERISCHE NATIONALBANK | Major Banks | Director of Finance/CFO Chief Executive Officer | |
LGT Capital Partners AG
LGT Capital Partners AG Investment ManagersFinance LGT Capital Partners AG (LGT Capital Partners) is a venture capital subsidiary of LGT Holding International AG founded in 1997 by Thomas Weber. The firm is headquartered in Pfäffikon, Switzerland. | Investment Managers | Private Equity Analyst | |
LGT Capital Partners (FL) AG
LGT Capital Partners (FL) AG Investment ManagersFinance LGT Capital Partners (FL) AG (LGT CP) is the alternative investment management subsidiary of LGT Capital Partners AG, itself a subsidiary of the Prince of Liechtenstein Family’s LGT Group Foundation. Established in 1998, the firm is located in Vaduz and provides asset management services to national and local government pension funds, corporate pension funds, sovereign wealth funds, insurance companies, foundations, endowments and banks. They provide alternative investment solutions to institutional investors through a broad range of fund of funds programs and align interests by investing substantial proportions of their own assets in the same programs as clients. The LGT Group also invests a significant part of their proprietary capital in the firm's investment programs. | Investment Managers | Portfolio Manager-Equities | |
MediaCorp Pte Ltd.
MediaCorp Pte Ltd. BroadcastingConsumer Services MediaCorp Pte Ltd. provides media and entertainment services. It operates television networks and stations. The firm offers platforms, spanning television, radio, newspapers, magazines, movies, and digital media services. The company is headquartered in Singapore. | Broadcasting | Private Equity Investor | |
Mardec Bhd
Mardec Bhd Miscellaneous ManufacturingProducer Manufacturing Part of Prisma Spektra Sdn. The company is based in Ampang, Malaysia. Bhd., Mardec Bhd is a Malaysian company that manufactures and trades rubber and rubber-related products, and engages in investment holding. Bhd. from Semi Bayu Sdn Bhd on October 10, 2011 for $40.88 million. Mahmood Abdul Kadir has been the CEO of the company since 1975. Mardec was acquired by Prisma Spektra Sdn. | Miscellaneous Manufacturing | Director/Board Member | |
RONGAN PROPERTY CO.,LTD. | Real Estate Development | Director/Board Member | |
The University of Queensland | College/University | Graduate Degree | |
University of St. Gallen | College/University | Graduate Degree | |
INNUOVO TECHNOLOGY CO., LTD. | Other Metals/Minerals | Director/Board Member | |
London School of Economics & Political Science | College/University | Graduate Degree | |
University of Basel | College/University | Doctorate Degree Doctorate Degree | |
University of Zurich | College/University | Corporate Officer/Principal Graduate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Chief Administrative Officer Doctorate Degree Graduate Degree | |
Nanyang Technological University | College/University | Masters Business Admin | |
Evolma Holding AG | Chairman Director/Board Member | ||
Systag System Technik AG
Systag System Technik AG Medical SpecialtiesHealth Technology Systag System Technik AG specializes in laboratory automation. The private company is based in Ruschlikon, Switzerland. The Swiss company has been a leading partner for chemical and pharmaceutical production facilities worldwide since 1965. The CEO of the company is Marcel Haugg. | Medical Specialties | Chairman Director/Board Member | |
Zhejiang University | College/University | Corporate Officer/Principal | |
London Business School | College/University | Graduate Degree | |
HENGDIAN GROUP DMEGC MAGNETICS CO. ,LTD | Metal Fabrication | Director/Board Member | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
GUANGBO GROUP STOCK CO., LTD. | Office Equipment/Supplies | Director/Board Member | |
SHANXI SECURITIES CO., LTD. | Investment Banks/Brokers | Director/Board Member | |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
LGT Capital Partners AG (Investment Management)
LGT Capital Partners AG (Investment Management) Investment ManagersFinance LGT Capital Partners AG (Investment Management) (LGT Capital Partners-IM) is the Swiss alternative investment arm of LGT Capital Partners AG, ultimately held by the Von und zu Liechtenstein family’s LGT Group Foundation in Liechtenstein. Headquartered in Pfäffikon, the firm was founded by Thomas Weber and Roberto Paganoni in 1997. LGT Capital Partners-IM manages a wide range of investment programs that focus on private markets, liquid alternatives and multi-asset solutions on behalf of pension funds, insurance companies, sovereign wealth funds, banks, asset managers, endowments and foundations. They make it possible for clients to invest their assets using the same endowment-like strategy as their owners, the Princely Family of Liechtenstein. | Investment Managers | Analyst-Equity | |
Mckinsey & Co., Inc. (Switzerland) | Corporate Officer/Principal | ||
Study Center Gerzensee Foundation | Director/Board Member Chairman | ||
Systems Engineering Society of China | Director/Board Member | ||
Albin Kistler AG
Albin Kistler AG Investment ManagersFinance Albin Kistler AG is a traditional asset and private wealth management firm headquartered in Zurich, Switzerland. The firm was founded by Norbert Albin and André Kistler in 1995 and they are a subsidiary of Graubuendner Kantonalbank, which is ultimately held by the State of Graubunden. Albin Kistler provides wealth management for domestic and international private and corporate clients as well as foundations and pension funds. | Investment Managers | Analyst-Fixed Income | |
MFC Beteiligungs AG | Chairman Chairman | ||
ZHEJIANG SHAOXING RUIFENG RURAL COMMERCIAL BANK CO.,LTD | Regional Banks | Director/Board Member | |
Berner Kantonalbank AG (Investment Management)
Berner Kantonalbank AG (Investment Management) Investment ManagersFinance Berner Kantonalbank AG (Investment Management) (BEKB) is the investment management division of State-owned Berner Kantonalbank AG in Switzerland. Headquartered in Bern, BEKB was founded in 1834 and offers innovative asset management solutions for private individuals as well as for business and corporate customers - particularly for SMEs. | Investment Managers | Chief Investment Officer | |
Dottikon Es Management AG | Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
InvestKL Corp. | Director/Board Member | ||
Cambridge Judge Business School | College/University | Graduate Degree | |
Raiffeisenbank Vierwaldstättersee-Süd Genossenschaft
Raiffeisenbank Vierwaldstättersee-Süd Genossenschaft Major BanksFinance Raiffeisenbank Vierwaldstättersee-Süd Genossenschaft provides commercial banking services. It offers mortgage loans, credit cards, billing payments, pension consulting, car loans, investment and financing, risk and hedging, and liquidity and investment services. The company was founded on April 10, 1910 and is headquartered in Buochs, Switzerland. | Major Banks | Chief Executive Officer | |
HENGDIAN ENTERTAINMENT CO.,LTD | Movies/Entertainment | Director/Board Member | |
Brunel Business School | College/University | Graduate Degree | |
Quaero Life Science Co., Ltd.
Quaero Life Science Co., Ltd. Medical SpecialtiesHealth Technology Quaero Life Science Co., Ltd. engages in the development, manufacture, and sale of in vitro diagnostic instruments and life science consumables. It offers immunoassay analyzers, automatic genital tract secretion analyzers, robotic tips, and polymerase chain reaction (PCR) kits. The company was founded on June 1, 2009 and is headquartered in Jiaxing, China. | Medical Specialties | Director/Board Member | |
Dr Pascal Sieber & Partners Ag | Founder | ||
Bern Congress Organiser (BCO) GmbH | College/University | Corporate Officer/Principal | |
BRIACELL THERAPEUTICS CORP. | Biotechnology | Chief Tech/Sci/R&D Officer | |
GUOSEN SECURITIES CO., LTD. | Investment Banks/Brokers | Director/Board Member |
Statistieken
Internationaal
Zwitserland | 24 |
China | 12 |
Verenigde Staten | 5 |
Verenigd Koninkrijk | 5 |
Singapore | 3 |
Sectoraal
Consumer Services | 15 |
Finance | 14 |
Health Technology | 9 |
Producer Manufacturing | 5 |
Commercial Services | 3 |
Operationeel
Director/Board Member | 74 |
Corporate Officer/Principal | 46 |
Chairman | 37 |
Graduate Degree | 18 |
Chief Executive Officer | 17 |
Sterkste connecties
Insiders | |
---|---|
Alfred Scheidegger | 20 |
Thomas Früh | 17 |
Peter Grogg | 14 |
Paul H. Arni | 12 |
Yue Xiang Jiang | 12 |
Thomas Jakob Ulrich Jordan | 11 |
Noor Amy Ismail | 10 |
Markus Blocher | 10 |
Johannes Hopf | 8 |
Marlene Born | 8 |
Stephan Kirschbaum | 7 |
Pascal Sieber | 7 |
Thomas Wiedmer | 7 |
Markus Lacher | 7 |
Michel Galeazzi | 7 |
- Beurs
- Insiders
- Emanuel Tschannen
- Bedrijfsconnecties